Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    21081550 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed PLASMA 2 Trial: Examination of Once Daily (QD) Dosing of A-002 In Subjects With Stable Coronary Artery Disease
Condition: Coronary Artery Disease
Intervention: Drug: A-002

Study has passed its completion date and status has not been verified in more than two years.